Venmax Drugs & Pharmaceuticals Shareholding

Venmax Drugs & Pharmaceuticals Ltd Shareholding Pattern

The Venmax Drugs & Pharmaceuticals Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Venmax Drugs & Pharmaceuticals Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Venmax Drugs & Pharmaceuticals Ltd (NSE: , BSE: 531015) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Venmax Drugs & Pharmaceuticals Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Venmax Drugs & Pharmaceuticals Ltd Shareholding Pattern (Latest)

The latest Venmax Drugs & Pharmaceuticals Ltd shareholding for Dec 2025 is:

• Promoters: 15.14%
• FII: 0%
• DII: 0%
• Public: 84.86%
• Government: 0%

A slight decline in promoter holding may indicate stake dilution or strategic selling.

Venmax Drugs & Pharmaceuticals Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Venmax Drugs & Pharmaceuticals Ltd.

• Dec 2025: 15.14%
• Sept 2025: 23.14%
• Jun 2025: 23.14%
• Mar 2025: 23.14%
• Dec 2024: 23.14%

Promoter stake remains largely stable, showing consistent ownership structure.

Venmax Drugs & Pharmaceuticals Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Venmax Drugs & Pharmaceuticals Ltd.

• Dec 2025: 0%
• Sept 2025: 0%
• Jun 2025: 0%
• Mar 2025: 0%
• Dec 2024: 0%

FII holding has declined, suggesting cautious sentiment among foreign investors.

Venmax Drugs & Pharmaceuticals Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

• Dec 2025: 0%
• Sept 2025: 0%
• Jun 2025: 0%
• Mar 2025: 0.15%
• Dec 2024: 0.15%

DII holdings remain stable, reflecting steady institutional participation.

Venmax Drugs & Pharmaceuticals Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

• Dec 2025: 84.86%
• Sept 2025: 76.86%
• Jun 2025: 76.86%
• Mar 2025: 76.72%
• Dec 2024: 76.72%

Public participation in Venmax Drugs & Pharmaceuticals Ltd has increased, indicating rising retail investor interest.

Venmax Drugs & Pharmaceuticals Ltd Government Holding

Government holding in Venmax Drugs & Pharmaceuticals Ltd currently stands at 0%.

Venmax Drugs & Pharmaceuticals Ltd operates without significant government ownership.

Venmax Drugs & Pharmaceuticals Ltd Shareholding Analysis Summary

The Venmax Drugs & Pharmaceuticals Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Investors should monitor changes in Venmax Drugs & Pharmaceuticals Ltd shareholding for signals on institutional sentiment and ownership trends.

Regular monitoring of the Venmax Drugs & Pharmaceuticals Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.